Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods

Authors:

Ginex Tiziana, Garaigorta Urtzi, Ramírez David, Castro Victoria, Nozal Vanesa, Maestro Inés, García-Cárceles Javier, Campillo Nuria E., Martinez Ana, Gastaminza Pablo, Gil Carmen

Journal:

Pharmaceuticals

Date of publication:

Tuesday, 6 April, 2021

Volume:

Issue:

Pages:

332

EVAg connections:

Research funded by EVAg

Published by EVAg end-user

EVAg

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods

EVAg Hotline

For tropical and RG4 viruses

For other human viruses of medical importance

For veterinary pathogens of economic importance

Scientific Publication:

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods